Summary by Moomoo AI
60 Degrees Pharmaceuticals, Inc. has formally requested the U.S. Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3, initially filed under File No. 333-280796. The company, headquartered in Washington, D.C., seeks to have the Registration Statement become effective at 9:00 a.m. Eastern Time on July 18, 2024, or as soon thereafter as practicable. This request, made pursuant to Rule 461 of the Securities Act of 1933, comes with the acknowledgment from the company that the SEC's declaration of effectiveness does not preclude further SEC action regarding the Registration Statement, nor does it absolve the company of its responsibility for the adequacy of the disclosure within the Registration Statement. The company also recognizes that it cannot use the SEC's comments or the effectiveness of the Registration Statement as a defense in any legal proceedings. Upon effectiveness, 60 Degrees Pharmaceuticals has requested oral confirmation from the SEC and a written order verifying the effective time and date to be sent to their counsel, Sichenzia Ross Ference Carmel LLP.